|

Intense androgen deprivation therapy Clinical Trials

1 actively recruiting trial

Also known as: ADT plus second-generation ARi

Pipeline

Phase 2: 1

Top Sponsors

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1

Indications

  • Prostate Cancer Metastatic Disease1
  • Cancer1

Other1 trial

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.